Claims
- 1. A method for the photometric in vitro determination of the content of oxygen in a blood sample, comprising:
- (a) transferring the blood sample to a sample container:
- (i) having an inlet opening and otherwise being essentially sealed; and
- (ii) incorporating a luminophor in a polymer matrix, whose luminescence is quenched in the presence of oxygen;
- (b) disposing the sample container in optical communication with an optical system comprising a radiation source and a radiation detector for detecting radiation transmitted from said source;
- (c) transmitting radiation from the radiation source to the sample container to excite the luminophor;
- (d) transmitting the luminescence emitted by the excited luminophor to the radiation detector; and
- (e) detecting and registering the luminescence.
- 2. A sample container for the photometric in vitro determination of the oxygen content in a blood sample, said sample container:
- (a) having an inlet opening and otherwise being essentially sealed; and
- (b) incorporating a luminophor in a polymer matrix whose luminescence is quenched in the presence of oxygen.
- 3. The sample container according to claim 2, wherein the polymer matrix forms a coating on a portion of the container.
- 4. The sample container according to claim 2, wherein the polymer matrix is cellulose acetate, polyurethane, polycarbonate/silicone copolymer, or hard polyvinyl chloride, and the luminophor is selected from among those porphyrin compounds which, when incorporated in the polymer matrix, provide a luminescence characteristic of a sufficient size variation allowing the actual oxygen partial pressure to be determined, as long as the ambient oxygen partial pressure varies within the physiological range of up to about 800 mm Hg.
- 5. The sample container according to claim 4, wherein the polymer matrix is polyvinyl chloride and the luminophor is arylsubstituted tetrabenzoporphyrin.
- 6. The sample container according to claim 5, wherein the polymer matrix is polyvinyl chloride and the luminophor is a palladium porphyrin.
- 7. The sample container according to claim 6, wherein the palladium porphyrin is selected from the group consisting of palladium(II)-tetraphenyl porphyrin (PdTPP) and palladium(II-tetra-(pentafluorophenyl)-porphyrin (PdTFPP).
- 8. The sample container according to claim 7, wherein the luminophor is palladium(II)-tetraphenyl porphyrin (PdTPP).
- 9. The sample container according to claim 7, wherein the luminophor is palladium(II-tetra-pentafluorophenyl)porphyrin (PdTFPP).
- 10. A system for the photometric in vitro determination of the content of oxygen in a blood sample, comprising:
- (a) a sample container;
- (i) having an inlet opening and otherwise being essentially sealed; and
- (ii) incorporating a luminophor in a polymer matrix, whose luminescence is quenched in the presence of oxygen; and
- (b) an analyzer;
- (i) having an optical system incorporating a radiation source and a radiation detector for detecting radiation transmitted from the radiation source;
- (ii) incorporating means for providing optical communication between the optical system and the sample container so that radiation transmitted from the radiation source is transmitted to the sample container such that the luminophor is excited and the luminescence emitted by the excited luminophor is transmitted to and detected by the radiation detector; and
- (iii) incorporating means for measuring the luminescence detected by the radiation detector.
- 11. The system according to claim 10, wherein the luminophor in the polymer matrix forms a coating on a portion of the sample container.
- 12. The system according to claim 11, wherein the polymer matrix is cellulose acetate, polyurethane, polycarbonate/silicone copolymer, or hard polyvinyl chloride, and the luminophor is selected from among those porphyrin compounds which, when incorporated in the polymer matrix, provide a luminescence characteristic of a sufficient size variation allowing the actual oxygen partial pressure to be determined, as long as the ambient oxygen partial pressure varies within the physiological range of up to about 800 mm Hg.
- 13. The system according to claim 12, wherein the polymer matrix is polyvinyl chloride and the luminophor is arylsubstituted tetrabenzoporphyrin.
- 14. The system according to claim 12, wherein the polymer matrix is polyvinyl chloride and the luminophor is a palladium porphyrin.
- 15. The system according to claim 14, wherein the palladium porphyrin is selected from the group consisting of palladium(II)-tetraphenyl porphyrin (PdTPP) and palladium(II-tetra-(pentafluorophenyl)-porphyrin (PdTFPP).
- 16. The system according to claim 15, wherein the luminophor is palladium(II)-tetraphenyl porphyrin (PdTPP).
- 17. The system according to claim 15, wherein the luminophor is palladium(II-tetra-pentafluorophenyl)-porphyrin (PdTFPP).
Priority Claims (2)
Number |
Date |
Country |
Kind |
7162/88 |
Dec 1988 |
DKX |
|
PCT/DK89/00300 |
Dec 1989 |
WOX |
|
Parent Case Info
This is a continuation of Ser. No. 08/147,087 filed Nov. 3, 1993, now abandoned; which is a continuation of Ser. No. 07/720,532 filed Jun. 21, 1991, now abandoned; and which is a continuation-in-part of Ser. No. 125,407 filed Nov. 25, 1987, now abandoned.
US Referenced Citations (24)
Continuations (2)
|
Number |
Date |
Country |
Parent |
147087 |
Nov 1993 |
|
Parent |
720532 |
Jun 1991 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
125407 |
Nov 1987 |
|